Evolution of the Average Target: Medical Properties Trust, Inc.

Evolution of the Average Target - Medical Properties Trust, Inc.

Evolution of the Target Price: Medical Properties Trust, Inc.

Evolution of the Target Price - Medical Properties Trust, Inc.

Changes in Analyst Recommendations: Medical Properties Trust, Inc.

3cd3fd3d9c.CZ3m2qiguetzA4QepTEEVwoKT4E0lgwB5PMqf2zb6js.P8-is-7z5twHYelXznYzIX1tCe4Z8VRI3b9uOzuz321B9a6J7JSNoDxl5w~69942aaa7eb4707e4488f4d43e40995a
17/08 BofA Securities Adjusts Medical Properties Trust Price Target to $4.25 From $5 MT
18/06 RBC Cuts Price Target on Medical Properties Trust to $4.50 From $5, Keeps Sector Perform, Speculative Risk MT
02/03 RBC Raises Price Target on Medical Properties Trust to $5 From $4.50, Keeps Sector Perform, Speculative Risk MT
30/25/30 RBC Lowers Price Target on Medical Properties Trust to $4.50 From $5, Keeps Sector Perform, Speculative Risk MT
12/25/12 BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Raises Price Target to $9 From $5 MT
10/25/10 RBC Raises Price Target on Medical Properties Trust to $5 From $4, Keeps Sector Perform, Speculative Risk MT
13/24/13 Colliers Upgrades Medical Properties Trust to Buy From Neutral, Price Target is $6.50 MT
12/24/12 Truist Securities Raises Price Target on Medical Properties Trust to $6 From $5, Maintains Hold Rating MT
02/24/02 BNP Paribas Exane Downgrades Medical Properties Trust to Neutral From Outperform, Adjusts Price Target to $4 From $6 MT
30/24/30 Truist Adjusts Price Target on Medical Properties Trust to $5 From $4.50, Maintains Hold Rating MT
14/24/14 RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 Amid Tenant-Related Concerns MT
14/24/14 RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 MT
17/24/17 Deutsche Bank Upgrades Medical Properties Trust to Hold From Sell, Adjusts PT to $5 From $2 MT
08/24/08 Truist Securities Raises Price Target on Medical Properties Trust to $4.50 From $4, Maintains Hold Rating MT
01/24/01 BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Price Target is $6 MT
20/24/20 RBC Cuts Price Target on Medical Properties Trust to $5 From $8 on Steward-Related Rent Disruption, Keeps Outperform, Speculative Risk MT
05/24/05 KeyBanc Downgrades Medical Properties Trust to Sector Weight From Overweight, Removes $15 Price Target Amid Uncertainty, Risks to Tenant Health MT
03/24/03 Mizuho Securities Adjusts Medical Properties Trust's Price Target to $7 From $9, Keeps Neutral Rating MT
28/23/28 RBC Cuts Price Target on Medical Properties Trust to $8 From $10, Keeps Outperform Rating MT
10/23/10 Stifel Downgrades Medical Properties Trust to Hold From Buy, Adjusts Price Target to $4.50 From $12 MT
16/23/16 Wells Fargo Downgrades Medical Properties Trust to Underweight From Equalweight, Cuts Price Target to $4 From $7 MT
31/23/31 Mizuho Downgrades Medical Properties Trust to Neutral From Buy, Adjusts Price Target to $9 From $18 MT
22/23/22 Barclays Adjusts Price Target on Medical Properties Trust to $10 From $12, Maintains Overweight Rating MT
21/23/21 JPMorgan Downgrades Medical Properties Trust to Underweight From Neutral, Adjusts Price Target to $7 From $9 MT
21/23/21 Analyst recommendations: Alphabet, AstraZeneca, FMC Corp, Target, Wise... Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+89.81%
+9.79%
+28.99%
+14.17%
+29.36%
+6.17%
+15.78%
+8.75%
+30.96%
+9.13%
Average +24.29%
Weighted average by Cap. +16.66%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
2.700USD
Average target price
5.125USD
Spread / Average Target
+89.81%
High Price Target
7.000USD
Spread / Highest target
+159.26%
Low Price Target
4.250USD
Spread / Lowest Target
+57.41%

Analyst Consensus Detail

Analyst consensus - Medical Properties Trust, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Medical Properties Trust, Inc.
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Medical Properties Trust, Inc.
  1. Stock Market
  2. Stocks
  3. MPT Stock
  4. Consensus Medical Properties Trust, Inc.